Jul 17, 2026 07:00AM

Jul 17, 2026 07:00AM

Jul 16, 2026 04:27PM

Jul 16, 2026 04:26PM

Nov 26, 2025 04:16PM

Jun 13, 2025 05:19PM

Nov 18, 2024 07:10AM Regenxbio (RGNX) Initiates Pivotal Phase Of Affinity Duchenne® Trial Of Rgx-202 Gene Therapy And Reports Positive Functional Data

Mar 6, 2024 11:40PM

Mar 6, 2024 11:20PM

Mar 6, 2024 04:11PM

Mar 6, 2024 04:10PM

Sep 1, 2023 04:30PM

Aug 4, 2023 04:32PM

Dec 30, 2022 04:19PM Form S-3ASR REGENXBIO Inc.

Jan 12, 2021 04:05PM

Jan 8, 2021 07:06AM

Jan 8, 2021 07:05AM

Jan 6, 2021 04:01PM

Jan 6, 2021 04:01PM

Aug 14, 2018 04:01PM

Aug 10, 2018 07:31AM Regenxbio (RGNX) Prices 2.7M Share Offering of Common Stock at $65/Share

Aug 10, 2018 07:30AM

Aug 8, 2018 04:55PM

Aug 8, 2018 04:07PM

Aug 8, 2018 04:05PM

Apr 26, 2017 04:01PM

Mar 22, 2017 05:36AM

Mar 21, 2017 09:31PM REGENXBIO Announces Pricing of Public Offering of Common Stock

Mar 21, 2017 04:03PM

Mar 21, 2017 04:01PM

Dec 29, 2016 04:17PM

Dec 16, 2016 05:02PM

71,748 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All